CorMedix (CRMD) Insider Trading & Ownership $9.48 -0.42 (-4.24%) (As of 01:00 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CorMedix (NASDAQ:CRMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$50,718.14Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.57 M Get CRMD Insider Trade Alerts Want to know when executives and insiders are buying or selling CorMedix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CRMD Insider Buying and Selling by Quarter Ad Brownstone ResearchMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. CorMedix Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/14/2024Elizabeth HurlburtEVPSell140,027$11.18$1,565,501.86 3/13/2024Joseph TodiscoCEOBuy13,561$3.74$50,718.14 (Data available from 1/1/2013 forward) CRMD Insider Trading Activity - Frequently Asked Questions Who is on CorMedix's Insider Roster? The list of insiders at CorMedix includes Elizabeth Hurlburt, Joseph Todisco, Matthew T David, and Myron Kaplan. Learn more on insiders at CRMD. What percentage of CorMedix stock is owned by insiders? 5.20% of CorMedix stock is owned by insiders. Learn more on CRMD's insider holdings. Which CorMedix insiders have been buying company stock? The following insider purchased CRMD shares in the last 24 months: Joseph Todisco ($87,818.14). How much insider buying is happening at CorMedix? Insiders have purchased a total of 23,561 CRMD shares in the last 24 months for a total of $87,818.14 bought. Which CorMedix insiders have been selling company stock? The following insider sold CRMD shares in the last 24 months: Elizabeth Hurlburt ($1,565,501.86). How much insider selling is happening at CorMedix? Insiders have sold a total of 140,027 CorMedix shares in the last 24 months for a total of $1,565,501.86 sold. CorMedix Key ExecutivesMr. Joseph Todisco MBA (Age 47)CEO & Director Compensation: $1.07MDr. Matthew T. David M.D. (Age 45)Executive VP & CFO Compensation: $597.27kMs. Erin Mistry (Age 41)Executive VP & Chief Commercial Officer Compensation: $561.57kMs. Elizabeth Masson-Hurlburt B.A. (Age 44)Executive VP and Chief Clinical Strategy & Operations Officer Compensation: $538.91kMs. Kaufman Beth Zelnick Esq.Executive VP, Chief Legal Officer & Corporate SecretaryDonna UcciSenior VP & Head of Global QualityDr. Tushar MukherjeeSenior VP & Head of Technical Operations More Insider Trading Tools from MarketBeat Related Companies CG Oncology Insider Transactions IDEAYA Biosciences Insider Transactions Longboard Pharmaceuticals Insider Transactions Keros Therapeutics Insider Transactions Centessa Pharmaceuticals Insider Transactions Akero Therapeutics Insider Transactions Janux Therapeutics Insider Transactions Mirum Pharmaceuticals Insider Transactions Amphastar Pharmaceuticals Insider Transactions Apogee Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:CRMD) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
